NKTR ($NKTR) Insider Trading & Smart Money Activity

NKTR · Biotechnology · Latest filing Jun 17, 2026

$NKTR has 2 insider trades on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($1.22M), net -$1.22M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$1.22M
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

NKTR insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 2 · $1.22M 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All NKTR insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Howard RobinPresident & CEO Sell (Open-market sale) 10b5-1 10K sh $611.88K +6.4%+12.0% Read
Insider Howard RobinPresident & CEO Sell (Open-market sale) 10b5-1 10K sh $611.88K +6.4%+12.0% Read

1W / 1M / 6M = how NKTR moved from the trade or filing date.

Insider trading in NKTR: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Howard Robin President & CEO 2 -$1.22M Jun 17, 2026

Frequently asked questions

Are NKTR insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 2 open-market sales worth $1.22M, a net -$1.22M.

What is the latest insider trade in NKTR?

Howard Robin, President & CEO filed a sell (open-market sale) of 10K sh worth $611.88K on Jun 17, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text